Dr. Adam Przybylkowski is the Head of Department of Gastroenterology and Internal Medicine at the Medical University of Warsaw and a member of the EMA’s Pharmacovigilance Risk Assessment Committee. For more than 10 years he has been active as an external expert for the Pharmacovigilance Department at The Office for Registration of Medicinal Products, Medical Devices And Biocidal Products in Poland, and offers his advice as a consultant in the area of Gastroenterology. He specializes in Pharmacoepidemiology, Pharmacovigilance, clinical and experimental Pharmacology, internal medicine and Gastroenterology, and for 6 years, he also held the function of alternate member at the PhVWP.